vs
Side-by-side financial comparison of Mind Medicine (MindMed) Inc. (DFTX) and Ivanhoe Electric Inc. (IE). Click either name above to swap in a different company.
Mind Medicine (MindMed) Inc. is the larger business by last-quarter revenue ($906.0K vs $896.0K, roughly 1.0× Ivanhoe Electric Inc.). Mind Medicine (MindMed) Inc. runs the higher net margin — -2634.0% vs -4500.4%, a 1866.5% gap on every dollar of revenue. On growth, Mind Medicine (MindMed) Inc. posted the faster year-over-year revenue change (-16.1% vs -32.7%).
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
Ivanhoe Electric Inc. is a critical minerals exploration and development firm focused on metals for global electrification. It targets high-grade copper, gold, silver and strategic deposits, with primary North American operations, supplying raw materials to renewable energy, EV and power grid infrastructure supply chains worldwide.
DFTX vs IE — Head-to-Head
Income Statement — Q4 FY2023 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $906.0K | $896.0K |
| Net Profit | $-23.9M | $-40.3M |
| Gross Margin | — | 69.5% |
| Operating Margin | -2450.8% | -4167.7% |
| Net Margin | -2634.0% | -4500.4% |
| Revenue YoY | -16.1% | -32.7% |
| Net Profit YoY | -386.7% | -318.3% |
| EPS (diluted) | $-0.58 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $896.0K | ||
| Q3 25 | — | $545.0K | ||
| Q2 25 | — | $1.1M | ||
| Q1 25 | — | $735.0K | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | — | $671.0K | ||
| Q2 24 | — | $538.0K | ||
| Q1 24 | — | $360.0K |
| Q4 25 | — | $-40.3M | ||
| Q3 25 | — | $-17.5M | ||
| Q2 25 | — | $-23.9M | ||
| Q1 25 | — | $-34.1M | ||
| Q4 24 | — | $18.5M | ||
| Q3 24 | — | $-43.2M | ||
| Q2 24 | — | $-46.8M | ||
| Q1 24 | — | $-60.1M |
| Q4 25 | — | 69.5% | ||
| Q3 25 | — | 51.2% | ||
| Q2 25 | — | 72.5% | ||
| Q1 25 | — | 60.1% | ||
| Q4 24 | — | 64.7% | ||
| Q3 24 | — | 61.8% | ||
| Q2 24 | — | 64.3% | ||
| Q1 24 | — | 72.2% |
| Q4 25 | — | -4167.7% | ||
| Q3 25 | — | -4328.3% | ||
| Q2 25 | — | -2400.3% | ||
| Q1 25 | — | -3674.0% | ||
| Q4 24 | — | -2229.4% | ||
| Q3 24 | — | -6233.8% | ||
| Q2 24 | — | -9023.4% | ||
| Q1 24 | — | -15800.3% |
| Q4 25 | — | -4500.4% | ||
| Q3 25 | — | -3214.9% | ||
| Q2 25 | — | -2233.2% | ||
| Q1 25 | — | -4645.0% | ||
| Q4 24 | — | 1386.6% | ||
| Q3 24 | — | -6443.5% | ||
| Q2 24 | — | -8695.7% | ||
| Q1 24 | — | -16693.1% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.13 | ||
| Q2 25 | — | $0.18 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | — | $0.36 | ||
| Q2 24 | — | $0.39 | ||
| Q1 24 | — | $0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.7M | $173.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $78.1M | $416.1M |
| Total Assets | $124.5M | $483.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $173.3M | ||
| Q3 25 | — | $69.5M | ||
| Q2 25 | — | $88.0M | ||
| Q1 25 | — | $98.2M | ||
| Q4 24 | — | $41.0M | ||
| Q3 24 | — | $81.1M | ||
| Q2 24 | — | $133.8M | ||
| Q1 24 | — | $179.4M |
| Q4 25 | — | $416.1M | ||
| Q3 25 | — | $280.1M | ||
| Q2 25 | — | $293.3M | ||
| Q1 25 | — | $307.0M | ||
| Q4 24 | — | $268.6M | ||
| Q3 24 | — | $250.1M | ||
| Q2 24 | — | $289.2M | ||
| Q1 24 | — | $331.5M |
| Q4 25 | — | $483.3M | ||
| Q3 25 | — | $386.2M | ||
| Q2 25 | — | $400.5M | ||
| Q1 25 | — | $414.4M | ||
| Q4 24 | — | $374.9M | ||
| Q3 24 | — | $375.4M | ||
| Q2 24 | — | $416.3M | ||
| Q1 24 | — | $461.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-20.6M | $-25.7M |
| Free Cash FlowOCF − Capex | — | $-25.7M |
| FCF MarginFCF / Revenue | — | -2872.8% |
| Capex IntensityCapex / Revenue | — | 4.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-90.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.7M | ||
| Q3 25 | — | $-27.7M | ||
| Q2 25 | — | $-20.0M | ||
| Q1 25 | — | $-15.8M | ||
| Q4 24 | — | $-30.7M | ||
| Q3 24 | — | $-36.9M | ||
| Q2 24 | — | $-44.5M | ||
| Q1 24 | — | $-50.0M |
| Q4 25 | — | $-25.7M | ||
| Q3 25 | — | $-27.8M | ||
| Q2 25 | — | $-21.3M | ||
| Q1 25 | — | $-15.8M | ||
| Q4 24 | — | $-32.4M | ||
| Q3 24 | — | $-36.9M | ||
| Q2 24 | — | $-45.0M | ||
| Q1 24 | — | $-50.6M |
| Q4 25 | — | -2872.8% | ||
| Q3 25 | — | -5103.9% | ||
| Q2 25 | — | -1990.1% | ||
| Q1 25 | — | -2146.5% | ||
| Q4 24 | — | -2432.4% | ||
| Q3 24 | — | -5506.6% | ||
| Q2 24 | — | -8372.9% | ||
| Q1 24 | — | -14064.2% |
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 16.9% | ||
| Q2 25 | — | 117.6% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 127.3% | ||
| Q3 24 | — | 8.8% | ||
| Q2 24 | — | 93.7% | ||
| Q1 24 | — | 186.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -1.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
